{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P81460",
      "entity_text" : "Con A",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5202",
      "entity_text" : "serotonin",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Hepatic serotonin levels increased insignificantly in Con A treated vs. vehicle and mirtazapine treated mice; however, mirtazapine treatment in Con A treated mice significantly increased hepatic serotonin levels, compared to both control groups (hepatic serotonin levels [pg/mg protein]; vehicle : 127.2 +/-17.2 vs. mirtazapine treated : 119.0 +/- 12.2 vs. Con A : 157.0 +/- 11.3 vs. Con A + mirtazapine : * 192.6 +/- 23.1; * p < 0.05 vs. vehicle and mirtazapine groups; n = 4-5 mice per group).",
  "reading_complete" : "2020-08-04T11:28:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:25:15Z",
  "trigger" : "increased",
  "evidence" : [ "serotonin levels increased insignificantly in Con A" ],
  "pmc_id" : "6474187",
  "score" : 0
}